S229-1115 Screening compound: N-[(3S4S)-4-(HYDROXYMETHYL)-1-[(1-METHYL-1H-PYRROL-2-YL)METHYL]PIPERIDIN-3-YL]BENZAMIDE

S229-1115 Screening compound: N-[(3S4S)-4-(HYDROXYMETHYL)-1-[(1-METHYL-1H-PYRROL-2-YL)METHYL]PIPERIDIN-3-YL]BENZAMIDE
S229-1115 Screening compound: N-[(3S4S)-4-(HYDROXYMETHYL)-1-[(1-METHYL-1H-PYRROL-2-YL)METHYL]PIPERIDIN-3-YL]BENZAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound S229-1115
N-[(3S4S)-4-(HYDROXYMETHYL)-1-[(1-METHYL-1H-PYRROL-2-YL)METHYL]PIPERIDIN-3-YL]BENZAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S229-1115

Molecular Formula

C19H25N3O2 (C19 H25 N3 O2)

Compound Name

N-[(3S4S)-4-(HYDROXYMETHYL)-1-[(1-METHYL-1H-PYRROL-2-YL)METHYL]PIPERIDIN-3-YL]BENZAMIDE

IUPAC name

N-[(3S4S)-4-(hydroxymethyl)-1-[(1-methyl-1H-pyrrol-2-yl)methyl]piperidin-3-yl]benzamide

SMILES

Cn1c(CN(CC[C@H]2CO)C[C@@H]2NC(c2ccccc2)=O)ccc1

InChI

InChI=1S/C19H25N3O2/c1-21-10-5-8-17(21)12-22-11-9-16(14-23)18(13-22)20-19(24)15-6-3-2-4-7-15/h2-8,10,16,18,23H,9,11-14H2,1H3,(H,20,24)/t16-,18-/m0/s1

InChI Key

PBGLOBMKXNNWCN-WMZOPIPTSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

327.43

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

1.489

Distribution Coefficient, logD

1.460

Water Solubility, LogSw

-1.89

Polar Surface Area

48.254

Acid Dissociation Constant (pKa)

13.51

Base Dissociation Constant (pKb)

6.23

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

42.10

S229-1115 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S229-1115 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S229-1115?
Check Price and Availability of S229-1115, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S229-1115 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S229-1115
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S229-1115
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S229-1115 available by request